An update from Bayer ( (DE:BAYN) ) is now available.
Bayer AG announced a transaction involving Horst Baier, a member of its supervisory board, who purchased shares as part of the board members’ commitment to buy Bayer AG shares. This transaction, conducted on the Xetra platform, reflects the board’s confidence in the company’s future prospects and is likely to impact investor sentiment positively.
More about Bayer
Bayer Aktiengesellschaft is a global enterprise with core competencies in the life science fields of health care and agriculture. The company is known for its pharmaceutical products, consumer health products, and crop science division, focusing on innovative solutions in health and nutrition.
YTD Price Performance: 21.40%
Average Trading Volume: 754,296
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €22.84B
For detailed information about BAYN stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com